IL1B and neoplasm: Thus, our results suggest that therapeutic treatment can cooperate with PAMPs and DAMPs in a tumour microenvironment to induce more IL-1β secretion, which consequently results in efficient tumour suppression by recruiting neutrophils, especially immunostimulatory N1 TANs.